Entity
  • HealthtechTAB - Healthtech Translation Advisory Board

    Created in 2018


  • To investigate (B)
    Some signals may appear as inconsistent with a regular activity
  • Social networks

    74 157
  • Entity types

  • Location

    Campus de Azurém, Av. da Universidade, 4800-058 Guimarães, Portugal

    Guimarães

    Portugal

  • Employees

    Scale: 11-50

    Estimated: 1

  • Engaged catalyst

    1
    0 0
  • Added in Motherbase

    5 years, 2 months ago
Description
  • Value proposition

    We bring together a unique group of healthtech industry experts to guide new projects in the road to translation.

    The HealthtechTAB is an EC-funded instrument that brings together a unique group of seasoned healthtech industry experts and entrepreneurs with a solid track record in developing and bringing new therapeutics and medical devices from bench to bedside.

    Our support includes access to the characterisation and pilot manufacturing services of the Nanomedicine Translation Hub, as well as opportunities to discuss partnerships with leading corporations or to raise funds from investors.

    The HealthtechTAB is a free-of-charge service sponsored by the European Commission. No equity is taken or payback required, and you fully retain your IP.

    It builds on the success of the nanomedTAB (Nanomedicine Translation Advisory Board), which supported 84 projects, and helped raising more than 15 million euros in funding in less than 3 years of operation.

    We tailor our support to the needs of carefully selected healthtech projects at different stages of development, using a holistic approach to assess, guide and monitor healthtech development in one team. Contrarily to most programs, our support is not limited to a predefined timescale. We will help you along the journey provided that milestones are successfully reached.


Catalyst interactions
Catalyst TypeTweets Articles
Bayer
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Other

6 May 2021


Social network dynamics
Loading...